Injection site for GLOW stack if you're on a GLP-1 like semaglutide or tirzepatide

Understanding the GLOW Stack with GLP-1 Medications

As the founder of CFP Weight Loss and author of The CFP Method, I've helped thousands navigate the complexities of combining peptide therapies with GLP-1 agonists like semaglutide and tirzepatide. The GLOW stack—typically a blend of growth hormone-releasing peptides, B vitamins, and metabolic enhancers—pairs powerfully with these GLP-1s to accelerate fat loss while preserving muscle. However, proper injection site selection becomes critical when layering therapies to avoid tissue irritation and ensure optimal absorption.

GLP-1 medications are usually injected subcutaneously in the abdomen, thigh, or upper arm. When adding the GLOW stack, you must rotate sites strategically. Abdominal injections for the GLOW stack often yield the fastest uptake due to higher vascularity, but this area is also common for weekly GLP-1 doses. Overlapping can cause localized inflammation, especially for those managing diabetes, blood pressure, and hormonal shifts common in the 45-54 age group.

Recommended Injection Sites and Rotation Strategy

For the GLOW stack, I recommend the following primary sites in order of p